# Acrylamide Exposure Exacerbates Type 2 Diabetes-Induced Neurotoxicity: An Integrated Neurobehavioral and Molecular Investigation

**Authors:** Abdulaziz Arif A. Alshammari, Abdullah Saleh Alkhamiss, Minhajul Arfeen, Razan Alawaji, Mai B. Alwesmi, Vasudevan Mani

PMC · DOI: 10.3390/life16030491 · Life · 2026-03-17

## TL;DR

This study shows that acrylamide exposure worsens brain damage in diabetic rats, leading to increased cognitive decline and neurotoxic effects.

## Contribution

The study reveals a novel synergistic neurotoxic effect of acrylamide and T2DM on cognitive and molecular brain health.

## Key findings

- T2DM and acrylamide exposure together increased oxidative stress and neuroinflammation markers.
- Cognitive deficits were observed in diabetic rats exposed to acrylamide.
- Neuroapoptosis markers like Bax and Caspase-3 were elevated in the combined exposure group.

## Abstract

Type 2 Diabetes Mellitus (T2DM) is a widespread metabolic disorder that can affect brain health, primarily through the damaging effects of prolonged hyperglycemia. This condition increases oxidative stress (OS), neuroinflammation, and neuroapoptosis, ultimately impairing cognitive function. Acrylamide (ACY), a neurotoxicant formed during high-temperature food processing and present in cigarette smoke, may further aggravate these neurological disturbances. The present experiment examined the exacerbating effects of T2DM and ACY exposure on cognitive function, neurodegeneration, OS, neuroinflammation, and neuroapoptosis in diabetic rats. T2DM was induced via intraperitoneal injections of nicotinamide and streptozotocin, followed by daily oral doses of ACY for a month. Behavioral assessments (EPM, NOR, and Y-maze) evaluated cognitive performance. Brain tissues were analyzed for biochemical markers of neurodegeneration (GSK-3β, AChE, BACE1), OS (MDA, GSH, Catalase), neuroinflammation (NF-κB, TNF-α, PGE2, COX-2), and neuroapoptosis (Bcl-2, Bax, Caspase-3). Immunohistochemistry of Bcl-2, Bcl-6, CD138, and NF assessed structural brain changes. Results indicated that T2DM and ACY exposure significantly increased the incidence of neurological disturbances. Notably, through increased COX-2, PGE2, MDA, Bax, Bcl-6, Caspase-3, and cognitive decline deficits. This study highlights the harmful neurotoxic amplification of T2DM and ACY exposure, emphasizing the importance of public health measures to reduce ACY exposure through dietary and lifestyle changes, particularly among T2DM populations. Further research into neuroprotective strategies and underlying mechanisms is necessary.

## Linked entities

- **Proteins:** GSK3B (glycogen synthase kinase 3 beta), ACHE (acetylcholinesterase (Yt blood group)), BACE1 (beta-secretase 1), NFKB1 (nuclear factor kappa B subunit 1), TNF (tumor necrosis factor), COX2 (cytochrome c oxidase subunit II), BCL2 (BCL2 apoptosis regulator), BAX (BCL2 associated X, apoptosis regulator), Casp3 (caspase 3), BCL6 (BCL6 transcription repressor), SDC1 (syndecan 1)
- **Chemicals:** acrylamide (PubChem CID 6579), nicotinamide (PubChem CID 936), streptozotocin (PubChem CID 29327), MDA (PubChem CID 1614), GSH (PubChem CID 124886), PGE2 (PubChem CID 5280360)
- **Diseases:** Type 2 Diabetes Mellitus (MONDO:0005148), Type 2 Diabetes (MONDO:0005148)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, Nfasc (neurofascin) [NCBI Gene 116690] {aka NF}, Bcl6 (BCL6, transcription repressor) [NCBI Gene 303836], Bace1 (beta-secretase 1) [NCBI Gene 29392] {aka Bace}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], Cat (catalase) [NCBI Gene 24248] {aka CS1, Cas1, Cat01, Catl, Cs-1}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 84027], Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Tnf (tumor necrosis factor) [NCBI Gene 24835] {aka RATTNF, TNF-alpha, Tnfa}, Ptgs2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 29527] {aka COX-2, Cox2, PGHS-2, PHS II, Pghs2}, Ache (acetylcholinesterase) [NCBI Gene 83817]
- **Diseases:** T2DM (MESH:D003924), metabolic disorder (MESH:D008659), neurodegeneration (MESH:D019636), diabetic (MESH:D003920), neuroinflammation (MESH:D000090862), cognitive decline deficits (MESH:D003072), Neurotoxicity (MESH:D020258), hyperglycemia (MESH:D006943), neurological disturbances (MESH:D009461)
- **Chemicals:** GSH (MESH:D005978), ACY (MESH:D020106), streptozotocin (MESH:D013311), nicotinamide (MESH:D009536), MDA (MESH:D015104)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028111/full.md

## Figures

17 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028111/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028111/full.md

---
Source: https://tomesphere.com/paper/PMC13028111